Application Support Analyst @ Autolus Therapeutics | Jobright.ai
JOBSarrow
RecommendedLiked
0
Applied
0
External
0
Application Support Analyst jobs in United States
Be an early applicantLess than 25 applicants
expire-info-iconThis job has closed.
company-logo

Autolus Therapeutics · 2 hours ago

Application Support Analyst

ftfMaximize your interview chances
BiopharmaBiotechnology
Hiring Manager
Liam Kenyon
linkedin

Insider Connection @Autolus Therapeutics

Discover valuable connections within the company who might provide insights and potential referrals.
Get 3x more responses when you reach out via email instead of LinkedIn.

Responsibilities

Deliver technical support for software applications and ensure timely resolution of issues.
Monitor system performance, conduct updates, and perform routine maintenance.
Collaborate with internal teams and vendors to resolve application challenges.
Create and maintain documentation to enhance knowledge sharing and streamline support processes.
Develop and update troubleshooting articles for first- and second-line support teams.

Qualification

Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.

Software systems managementPharmaceutical systemsSoftware development life cycle

Required

Strong technical skills, with a focus on troubleshooting and resolving application issues.
Proficiency in managing software systems, with the ability to adapt and learn quickly.
Excellent communication and problem-solving abilities, with a user-focused approach.
Experience working collaboratively with cross-functional teams and stakeholders.

Preferred

Familiarity with pharmaceutical or commercial sales systems and software development life cycles.

Benefits

Private medical insurance
Life assurance
Pension plan
Flexible working options
Participation in an employee share scheme

Company

Autolus Therapeutics

twittertwitter
company-logo
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer.

Funding

Current Stage
Public Company
Total Funding
$1.13B
Key Investors
Blackstone GroupPPF GroupCormorant Asset Management
2024-02-08Post Ipo Equity· $350M
2022-12-08Post Ipo Equity· $149.87M
2021-11-08Post Ipo Equity· $250M

Leadership Team

leader-logo
Christian Itin
Chief Executive Officer
linkedin
leader-logo
Christopher Vann
Senior Vice President, Chief Operating Officer
linkedin
Company data provided by crunchbase
logo

Orion

Your AI Copilot